Advertisement Β· 728 Γ— 90

Posts by Tamer Onder

7. Results suggest chemical reprogramming achieves comparable rejuvenation to OSKM with more homogeneous responses and reduced cellular stress.

4 months ago 0 0 0 0

6. This is the first study applying the complete human-optimized chemical reprogramming protocol and directly comparing it to genetic approaches under matched experimental conditions.

4 months ago 0 0 1 0

5. In naturally aged primary fibroblasts, chemical reprogramming ameliorated multiple aging hallmarks without activating TERT or compromising fibroblast identity markers like COL1A1.

4 months ago 0 0 1 0

4. OSKM induced acute senescence during treatment, requiring a chase period to resolve. Chemical reprogramming reduced senescence during active treatment without requiring chase.

4 months ago 0 0 1 0

3. OSKM generated heterogeneous populations: some cells retained CD13-high fibroblast identity while others acquired the TRA-1-60 pluripotency marker. Chemical reprogramming produced uniform CD13-low populations without detectable TRA-1-60.

4 months ago 0 0 1 0

2. Both methods reduced senescence, mitochondrial ROS, and age-associated gene expression. Chemical reprogramming matched or exceeded OSKM efficacy on most markers.

4 months ago 1 0 1 0

1. We compared the latest human-optimized chemical reprogramming protocol against doxycycline-inducible OSKM in progerin-aged fibroblasts and primary fibroblasts from donors >80 years old.

4 months ago 0 0 1 0
Advertisement
Preview
Rejuvenation capacity of genetic versus human-optimized chemical reprogramming in cellular aging models Cellular reprogramming with transient OSKM expression can reverse aging phenotypes, but genetic factor delivery introduces heterogeneous expression, reprogramming-associated stress, and barriers for t...

www.biorxiv.org/content/10.1...

New preprint from our lab: "Rejuvenation capacity of genetic versus human-optimized chemical reprogramming in cellular aging models"
Performed by my talented graduate student @omercane.bsky.social

4 months ago 2 0 1 0

7. These results suggest chemical reprogramming achieves comparable rejuvenation to OSKM with more homogeneous responses and reduced cellular stress.

4 months ago 0 0 0 0

6. This is the first study applying the complete human-optimized chemical reprogramming protocol and directly comparing it to genetic approaches under matched experimental conditions.

4 months ago 0 0 1 0

5. In naturally old primary fibroblasts, chemical reprogramming ameliorated multiple aging hallmarks without activating TERT or compromising fibroblast identity markers like COL1A1.

4 months ago 0 0 1 0

4. OSKM induced acute senescence during treatment, requiring a chase period to resolve. Chemical reprogramming reduced senescence during active treatment without requiring chase.

4 months ago 0 0 1 0

3. OSKM generated heterogeneous populations: some cells retained CD13-high fibroblast identity while others acquired the TRA-1-60 pluripotency marker. Chemical reprogramming produced uniform CD13-low populations without detectable TRA-1-60.

4 months ago 0 0 1 0

2. Both methods reduced senescence, mitochondrial ROS, and age-associated gene expression. Chemical reprogramming matched or exceeded OSKM efficacy on most markers.

4 months ago 1 0 1 0

1. We compared the latest human-optimized chemical reprogramming protocol against doxycycline-inducible OSKM in progerin-aged fibroblasts and primary fibroblasts from donors >80 years old.

4 months ago 0 0 1 0
Preview
A chromatin-focused CRISPR screen identifies USP22 as a barrier to somatic cell reprogramming Communications Biology - Ubiquitin-specific peptidase 22 (USP22) is identified as a key chromatin-based barrier to human iPSC derivation through a chromatin-focused CRISPR-Cas9 screen.

Check our recent work on a CRISPR screen to identify regulators of human somatic cell reprogramming where we identify USP22 as an important factor. Now published @CommsBio. rdcu.be/ed1l6

1 year ago 4 2 1 0
Advert detailing a postdoctoral scientist position at EMBL Rome. Contact: jamie.hackett@embl.it

Advert detailing a postdoctoral scientist position at EMBL Rome. Contact: jamie.hackett@embl.it

Postdoc positions in epigenetics!

We have several opportunities to investigate big picture questions on (epi)genome function & mechanisms

Based @embl.org near Rome (Italy), we offer full scientific support/facilities, training & funding. Also...β˜€οΈπŸ›οΈπŸ•πŸ–οΈ

SeeπŸ‘‡or contact me for other options. Pls RS

1 year ago 81 56 0 10
Advertisement
A screenshot of a paper on bioarxiv illustrating the lack of blue sky share button!

A screenshot of a paper on bioarxiv illustrating the lack of blue sky share button!

Would you like to see @biorxivpreprint.bsky.social add a share to blue sky button?! I know I would! Share this post to let @richardsever.bsky.social @erictopol.bsky.social and others at bioarxiv know!

1 year ago 384 196 9 6

It’s all a big mess. And the word for spice in turkish is baharat

1 year ago 0 0 0 0

Looks good!

1 year ago 1 0 1 0